EFFECT OF SINGLE-DOSE IVERMECTIN THERAPY ON HUMAN ONCHOCERCA VOLVULUS INFECTION WITH ONCHOCERCAL OCULAR INVOLVEMENT

1994 International ophthalmology clinics  
Ivermectin has shown promise as a potentially safe and effective microfilaricidal drug for the treatment of onchocerciasis. Several limited studies have shown it to have fewer side effects, especially ocular complications, than the currently available drug, diethylcarbamazine. The detailed ocular findings in 200 moderately to heavily infected Liberians who were enrolled in a safety and dose-finding study are presented. They received either 0, 100, 150, or 200
doi:10.1097/00004397-199400000-00012 fatcat:m3tac77mn5anvbthpikzn4jrpm